Cannabidiol, pharmaceutically produced with < 5 ppm THC

Drug identity checked against registry records

Also recorded as CardiolRx

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk FactorsNCT04615949CRDLPhase 2, Phase 3Terminated2022-11-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.